FDA OKs SMA Gene Therapy Itvisma – Medscape

1. FDA OKs SMA Gene Therapy Itvisma  Medscape
2. Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)  Novartis
3. Muscular Dystrophy…

Continue Reading